Evidence map›Paper›PMID 42750867›Full record

ReviewOncology reviews2026

Beyond tobacco: understanding the growing burden of lung adenocarcinoma in women.

Michael Christian A Virata, Rizal Michael Ramos Abello, Edroico Mari Beltran Brillante, Jasmine Soco Interior, Patrick Reyes Relacion, Ryan Gabriel C Molen, Eryll Paolo M Alea, John Cedric P Mojica

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Oncology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael Christian A VirataDepartment of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Rizal Michael Ramos AbelloDepartment of Family Medicine, Guthrie - Robert Packer Hospital, Sayre, PA, United States.
Edroico Mari Beltran BrillanteCollege of Medicine, San Beda University, Manila, Philippines.
Jasmine Soco InteriorMapua School of Medicine, Mapua University Makati, Makati, Philippines.
Patrick Reyes RelacionCollege of Allied Health Professions, University of the East Ramon Magsaysay Memorial Medical Center, Inc., Quezon City, Philippines.
Ryan Gabriel C MolenSchool of Medicine and Public Health, Ateneo de Manila University, Pasig, Philippines.
Eryll Paolo M AleaFaculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines.
John Cedric P MojicaCollege of Medicine, University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary lung adenocarcinoma is the most common histological subtype of lung cancer. It disproportionately affects female sex, especially never-smokers. The rising incidence among females without a smoking history suggests roles for hormonal, genetic, and environmental factors. We conducted a comprehensive literature review using several databases. We examined global epidemiology data, molecular mechanisms, hormone-related pathways, and new diagnostic and therapeutic approaches. The findings show that estrogen signaling, especially via estrogen receptor beta (ERβ), contributes to oncogenesis. The mechanism involves cross-talk with

Indexed as

EGFRestrogenestrogen receptor betaKRASlung adenocarcinomasmoking

Identifiers

PMID42750867
PMCPMC13579004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.